eLetters

154 e-Letters

published between 2008 and 2011

  • In vivo amyloid imaging in cortical superficial siderosis: Author's response to Linn J.'s rapid response letter
    Rik Vandenberghe

    We thank J. Linn for her interest in our paper.

    Following acceptance of the final version of our in vivo amyloid imaging paper in December 2009 (1), 2 subsequent papers (2,3) were published that used a different methodology and design but were in full accordance with our findings. In our paper, we report the clinical history, CT, MR and in vivo amyloid imaging in 2 cases with cortical superficial siderosis. Both ca...

    Show More
  • Cortical superficial siderosis as the only MRI sign of cerebral amyloid angiopathy
    Jennifer Linn

    With great interest, I read the letter by Dhollander et al. (1). The authors report two cases with convexity subarachnoid hemorrhages,cortical superficial siderosis (SS)and raised b-amyloid load on PIB-PET examination. Based on the absence of micro- and macrobleeds in one patient, they conclude that this case differs from cerebral amyloid angiopathy (CAA). However, I would like to draw attention to recently published fi...

    Show More
  • Rituximab in CIDP: a retrospective study
    Luana Benedetti

    We thank Zara G for her interest in our paper on "Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a report of 13 cases and review of the literature" (1). Most of her comment reflect indeed what we reported and discussed in the manuscript. We would like just to make a few comments to clarify some aspects. We were induced to perform this study by the few anecdotal reports (2-4)...

    Show More
  • Response to Dr Morrish
    Michael R Rose
    Dr Morrish is quite right to say that QoL questionnaire responses are influenced by mood. Indeed mood, but also other psycho-social factors, are liable to affect any subjective assessment. Subjective assessments include many of the patient reported outcome measures (PROMS) which are becoming increasingly popular, whether these are measuring QoL, patient satisfaction, function or other parameter. In our study the multiple regre...
    Show More
  • Is myelitis associated with Sjogren's syndrome a neuromyelitis optica spectrum disorder?
    Masahiro Mori

    Dear Editor,

    In 2005, our case report entitled 'Acute longitudinal myelitis as the initial manifestation of Sjogren's syndrome' was published in this journal (1). In that report, we described the case of a 31-year-old woman who presented with acute longitudinal myelitis extending along the entire spinal cord. She was also diagnosed with Sjogren's syndrome on the basis of positive anti-SS-A antibody test results a...

    Show More
  • Forget auditory nerve compression as a treatable cause for tinnitus
    Robert L. Folmer

    Dr. De Ridder overstates reality in the title of his editorial, "Auditory nerve compression: a forgotten treatable cause for tinnitus" and distorts reality in the text of the commentary. Examples of distortion include: there are no effective treatments available for most cases of tinnitus; auditory nerve compression is a common cause of tinnitus; carbamazepine and microvascular decompression surgery are viable treatment...

    Show More
  • Is there a role for facial motor evoked potentials in the microsurgical treatment of hemifacial spasm?
    Marcus A Acioly

    Marcus Andre Acioly, MD1,2 Florian Roser, MD1 Paulo Henrique Pires de Aguiar, MD2 Marcos Tatagiba, MD1 1 Department of Neurosurgery, University of Tuebingen, Germany 2 Department of Neurology, University of Sao Paulo, Brazil

    Dear Editor,

    The recent article by Fukuda et al.[1] documents a continuing interest in the study of a novel art of facial nerve (FN) monitoring. There are some important issues that...

    Show More
  • Comment on "Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature"
    Gabriella Zara

    I read with interest the paper by Benedetti et al., entitled 'Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature'(1). Rituximab, a monoclonal antibody that binds to the CD20 antigen on B- lymphocytes, has been approved to eliminate B cell precursors, normal and malignant B cells and to reduce antibody titers (2,3). Some authors argued tha...

    Show More
  • extradural cortical stimulation for post-stroke aphasia
    sergio canavero

    Extradural cortical stimulation (ECS) for post-stroke aphasia (PSA)

    Cherney et al (1) conducted an 8 patient controlled study whose conclusion was that ECS may enhance the effect of rehabilitation for PSA. This study was conducted by implanting the stimulating paddle supplied by NorthStar Neuroscience (NSN), a company now out of business. Cherney et al. point to several weaknesses of their study, but omit to dis...

    Show More
  • Trial design and current evidence for antibiotics-impregnated ventricular catheters in reducing infections
    George KC Wong

    To the editor,

    We thank Dr. Marini and colleagues for their interest in our article.1 They commented on the use of nosocomial infections as primary outcome and the randomised yet non-double-blinded study design. Secondarily, they shared their disappointing results from the utilization of antibiotics-impregnated ventricular catheters.

    In our centers, we have achieved a ventricular-catheter-related cere...

    Show More

Pages